Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2012 by Ludwig-Maximilians - University of Munich.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
PD Dr. med. Volker Heinemann, Ludwig-Maximilians - University of Munich
ClinicalTrials.gov Identifier:
NCT01384994
First received: May 2, 2011
Last updated: July 5, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)